The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

@article{Lind1999TheMS,
  title={The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.},
  author={Tore Lind and Francis M{\'e}graud and Peter Unge and Ekkehard Bayerdoerffer and Colm O'mor{\'a}in and Robin Spiller and Sander Veldhuyzen van Zanten and Karna D. Bardhan and M Hellblom and Michael Wrangstadh and Lena Zeijlon and Christer Cederberg},
  journal={Gastroenterology},
  year={1999},
  volume={116 2},
  pages={248-53}
}
BACKGROUND & AIMS The role of omeprazole in triple therapy and the impact of Helicobacter pylori resistance on treatment outcome are not established. This study investigated the role of omeprazole and influence of primary H. pylori resistance on eradication and development of secondary resistance. METHODS Patients (n = 539) with a history of duodenal ulcer and a positive H. pylori screening test result were randomized into 4 groups. OAC group received 20 mg omeprazole, 1000 mg amoxicillin… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 86 extracted citations

Similar Papers

Loading similar papers…